- Home
- EKSO vs MRKR Comparison
EKSO vs MRKR Comparison
Compare EKSO & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EKSO
- MRKR
- Stock Information
- Founded
- EKSO 2005
- MRKR N/A
- Country
- EKSO United States
- MRKR United States
- Employees
- EKSO N/A
- MRKR N/A
- Industry
- EKSO Medical/Dental Instruments
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- EKSO Health Care
- MRKR Health Care
- Exchange
- EKSO Nasdaq
- MRKR Nasdaq
- Market Cap
- EKSO 11.6M
- MRKR 11.8M
- IPO Year
- EKSO N/A
- MRKR N/A
- Fundamental
- Price
- EKSO $0.44
- MRKR $1.25
- Analyst Decision
- EKSO Strong Buy
- MRKR Strong Buy
- Analyst Count
- EKSO 2
- MRKR 3
- Target Price
- EKSO $5.00
- MRKR $13.17
- AVG Volume (30 Days)
- EKSO 107.1K
- MRKR 48.2K
- Earning Date
- EKSO 05-06-2025
- MRKR 05-14-2025
- Dividend Yield
- EKSO N/A
- MRKR N/A
- EPS Growth
- EKSO N/A
- MRKR N/A
- EPS
- EKSO N/A
- MRKR N/A
- Revenue
- EKSO $17,925,000.00
- MRKR $6,591,080.00
- Revenue This Year
- EKSO $25.17
- MRKR N/A
- Revenue Next Year
- EKSO $37.02
- MRKR N/A
- P/E Ratio
- EKSO N/A
- MRKR N/A
- Revenue Growth
- EKSO N/A
- MRKR 99.06
- 52 Week Low
- EKSO $0.34
- MRKR $0.95
- 52 Week High
- EKSO $1.53
- MRKR $5.99
- Technical
- Relative Strength Index (RSI)
- EKSO 55.45
- MRKR 52.07
- Support Level
- EKSO $0.39
- MRKR $1.16
- Resistance Level
- EKSO $0.43
- MRKR $1.25
- Average True Range (ATR)
- EKSO 0.04
- MRKR 0.10
- MACD
- EKSO 0.01
- MRKR 0.04
- Stochastic Oscillator
- EKSO 92.45
- MRKR 85.71
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.